Pharmascience Inc is proud to announce that it has acquired Uman Pharma Inc. on November 13, 2014.
Pharmascience's Global Injectables Division has been servicing the global pharmaceutical industry by providing high quality GMP contract manufacturing and R&D services, from early clinical development to commercial batches. Our focus is on niche generic oncology products.
Pharmascience’s Global Injectables Division offers contract manufacturing services for generic cytotoxic injectable drugs.
Sterile Manufacturing Plant:
Pharmascience’s facility situated in Candiac, Quebec is designed for manufacturing sterile forms of cytotoxic and high potency products. It is physically away from the main building and is serviced independently to avoid any risk of cross-contamination. We have strong expertise in the manufacturing of pre-filled syringes as well as vials, in either liposomal solution or emulsion forms. Vials can also present themselves in freeze-dried (lyophilized) forms.
At the main building, we are well equipped to handle formulation as well as packaging for clinical and commercial lots. In addition, the main building includes R&D and quality control laboratories as well as flexible storage options in controlled temperature rooms, walk-in freezers and refrigerators.
Whether you are looking for a contract manufacturer for an R&D project, a clinical trial, a technological transfer or a packaging partner, Pharmascience will ensure that your project is completed successfully. At Pharmascience, we are committed to providing added value services and creating long-lasting partnerships.
For inquiry, please contact: email@example.com.